JPRN-UMIN000015222
Completed
Phase 2
Phase II clinical trial of combination therapy with medium-chain triglycerides and ghrelin in patients with chronic obstructive pulmonary disease - Therapy with medium-chain triglycerides and ghrelin for chronic obstructive pulmonary disease
ational Hospital Organization Toneyama National Hospital0 sites10 target enrollmentOctober 1, 2014
ConditionsCOPD
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- COPD
- Sponsor
- ational Hospital Organization Toneyama National Hospital
- Enrollment
- 10
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\) Patients with malignant tumors 2\) Patients with active infection 3\) Patients with severe heart disease 4\) Patients with hepatic failure (serum levels of AST and ALT greater than twice the normal upper limits) 5\) Patients with renal failure (serum creatinine concentration \>\= 2\.0 mg/dL) 6\) Patients with asthma or who tested positive on an airway reversibility test 7\) Patients who are or could be pregnant 8\) Patients who are undergoing diabetes mellitus therapy or whose HbA1C\>7\.0 9\) Patients whose drug regimen was changed within one month before participation in this study 10\) In addition to the above exclusion criteria, patients judged to be inadequate to participate in this study by their physician
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 2
Phase 2 trial of first-line combination therapy of cisplatin, pemetrexed and nivolumab in participants with unresectable malignant pleural mesotheliomamalignant pleural mesotheliomaJPRN-UMIN000030892Okayama Rosai Hospital18
Not yet recruiting
Not Applicable
Phase I and II trial of combination therapy using nab-Paclitaxel+Pertuzumab+Trastuzumab for HER2 positive metastatic breast cancermetastatic breast cancerJPRN-UMIN000035869The University of Tokushima Graduate School, Depertment of Thoracic, Endocrine surgery and Oncology, Institute of Health Bioscience30
Active, not recruiting
Not Applicable
Phase II randomized trial of combination therapy of paclitaxel and bevacizumab versus paclitaxel, capecitabine and bevacizumab as first-line treatment for locally recurrent or metastatic breast cancer patients with HER2/neu negative tumor (ATX-study) - ATXEUCTR2006-006058-83-NLVU Medisch Centrum
Recruiting
Phase 2
A randomised phase II trial of combined therapy with CPT-11/CDDP versus CPT-11 alone in second-line treatment of advaneced or recurrent gastric cancer resistant to Docetaxel/Cisplatin/TS-1 (DCS) therapyGastric CancerJPRN-UMIN000003141Sapporo Medical University School of Medicine Dept. of Internal Medicine(4)80
Active, not recruiting
Phase 2
A phase II study for HER2 amplified advanced solid tumors (JUPITER trial)Solid tumorsHER2, solid tumorD009369JPRN-jRCT2031180150Ikeda Sadakatsu38